Shiro Sugiura Selected Research

Shiro Sugiura Research Topics

Disease

7	Food Hypersensitivity (Food Allergy) 04/2022 - 07/2016
6	Anaphylaxis (Anaphylactic Shock) 10/2018 - 09/2013
5	Hypersensitivity (Allergy) 01/2021 - 01/2016
5	Ischemia 11/2007 - 05/2003
4	Milk Hypersensitivity (Milk Allergy) 01/2022 - 10/2016
4	Infarction (Infarctions) 11/2007 - 02/2004
3	Wheat Hypersensitivity (Wheat Allergy) 10/2022 - 01/2020
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2007 - 08/2004
2	De Quervain Disease 11/2022 - 10/2019
2	Asthma (Bronchial Asthma) 01/2021 - 01/2018
2	Stroke (Strokes) 11/2007 - 08/2004
1	Allergic Rhinitis 01/2021
1	Dermatomyositis (Dermatopolymyositis) 09/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2019
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2019
1	Vitamin D Deficiency 04/2019
1	Peanut Hypersensitivity (Peanut Allergy) 01/2018
1	Neutropenia 01/2017
1	Exercise-Induced Allergies 08/2015
1	Squamous Cell Carcinoma of Head and Neck 02/2013
1	Dementia (Dementias) 11/2012
1	Infections 12/2007
1	Neck Pain (Cervicalgia) 12/2007
1	Brain Ischemia (Cerebral Ischemia) 04/2005
1	Ischemic Stroke 04/2005
1	Lymphoma (Lymphomas) 02/2004
1	Inflammation (Inflammations) 05/2003

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2004
5	Immunoglobulin E (IgE)IBA 01/2021 - 08/2015
5	Epinephrine (Adrenaline)FDA LinkGeneric 10/2018 - 04/2015
2	ErythritolIBA 01/2016 - 09/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2004 - 05/2003
1	AntigensIBA 04/2022
1	Caseins (Casein)FDA Link 01/2022
1	PhosphopeptidesIBA 01/2022
1	AutoantibodiesIBA 09/2019
1	Vitamin D FDA LinkGeneric 04/2019
1	hypoxanthine arabinoside (ara-H)IBA 01/2018
1	C-Reactive ProteinIBA 01/2017
1	GliadinIBA 08/2015
1	ClaudinsIBA 02/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2013
1	AntibodiesIBA 11/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2007
1	Pravastatin (Pravachol)FDA LinkGeneric 11/2007
1	RolipramIBA 05/2007
1	OligonucleotidesIBA 05/2007
1	Phosphodiesterase InhibitorsIBA 05/2007
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 05/2007
1	Bromodeoxyuridine (BrdU)IBA 05/2007
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 04/2005
1	Epidermal Growth Factor (EGF)IBA 04/2005
1	Heparin (Liquaemin)FDA LinkGeneric 04/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2005
1	Nylons (Nylon)IBA 04/2005
1	Nerve Growth Factors (Neurotrophins)IBA 04/2005
1	enhanced green fluorescent proteinIBA 08/2004
1	Liposomes (Liposome)IBA 08/2004
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2004
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2004
1	5-bromo-4-chloro-3-indolyl beta-galactoside (X-gal)IBA 02/2004
1	nimesulide (Aulin)IBA 01/2004
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2004
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2003
1	IsoenzymesIBA 05/2003
1	Glutamic Acid (Glutamate)FDA Link 05/2003

Therapy/Procedure

4	Immunotherapy 10/2022 - 01/2020
2	Conservative Treatment 11/2022 - 10/2019
1	Skin Care 04/2019
1	Artificial Respiration (Mechanical Ventilation) 01/2018
1	Intramuscular Injections 08/2015
1	Knee Replacement Arthroplasty (Total Knee Replacement) 12/2007
1	Intraventricular Injections 04/2005
1	Treatment Delay 05/2003